FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/11/2022
Voltar para busca
Dado oficial do USPTO
BELTEST-IT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
14/11/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
22/12/2020
Data de registro
05/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/07/2022
Última transação
05/07/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
01
Localização do titular
DE
Examinador
LOOK, JEFFREY
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "Beltest-it" in stylized blue letters with the "BEL" portion in dark blue and the rest of the letters in light blue.
Titulares e representantes
Titulares
R. B. (pessoa física)
PharmACT Holding AG
Representantes
Brian P. Gregg MCNEES WALLACE & NURICK
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
In-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical diagnosisbiological indicators for monitoring sterilization processes for medical purposes; diagnostic chemical reagents for medical use; reactants for medical diagnosis; diagnostic preparations for medical or veterinary purposes; cotton wool in the form of sticks for medical use; chemical reagents for veterinary use; cellulose wadding for medical purposes; diagnostic substances for medical use; reagents for use in analysis for veterinary purposes; enzymes for medical purposes; reagents for analytical purposes for veterinary purposes; tampons for medical purposes; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic testing materialschemical preparationschemical reagentstest stripsbiological indicators for medical use; enzyme preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for medical purposeschemical preparations for medical and veterinary diagnostic purposes; chemical preparations for medical purposes for the treatment of treatment or prophylaxis of the nervous systemdrug for treatment orprophylaxis of the endocrine systemdrug for treatment or prophylaxis of cardiovascular systeminjectable pharmaceutical for treatment or prophylaxis of respiratory tractinjectable pharmaceutical for treatment or prophylaxis of gastro intestinal tractinjectable pharmaceutical for treatment or prophylaxis of kidney or urinary tractinjectable pharmaceutical for treatment or prophylaxis of skininjectable vitaminsinjectable antibioticsinjectable synthetic chemotherapeutic agentsinjectable antimyoticsinjectable pharmaceuticals for treatment or prophylaxis of mycobacteriainjectable pharmaceuticals for treatment or prophylaxis of parasitesinjectable pharmaceuticals for treatment or prophylaxis of virus infectionsinjectable cytokine agentsinjectable immune suppressive agentsinjectable distinfectant agentsinjectable pharmaceuticals for treatment of malignant tumorsinjectable pharmaceuticals for treatment or prophylaxis of extracellular matrixinjectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorderinjectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatoseheterozygous familial hypercholesterolemiadiabetic foot syndromearterial hypertension or cardiac insufficiencyinjectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan levelinjectable pharmaceutical for treatment or prophylaxis of Alzheimer's diseasevascular dementiaParkinson's diseasemultiple sclerosisamyotrophic lateral sclerosis ALScerbral insultbrain traumacerebral inflammationsautoimmune encephalitisinjectable pharmaceutical for treatment or prophylaxis of radiation diseaseinjectable pharmaceutical for treatment or prophylaxis of tendovaginitisenthesiopathyinsertion tendinosisinsertion tendinopathytendinitisperiarthritisperiathrosisarthosisosteoarthritisfibrosisrenal fibrosisliver fibrosiscardiac fibrosiscardiac valve fibrosispulmonary fibrosispulmonary cirrhosispulmonary sclerosiscerebral insultcerebral strokeapoplectic insultapoplexia cerebriictus apoplecticuscerebral infarctionbrain scarsgliosiscontracturefibrotendinous contracturefibrous contracturejoint contracturetendon contractureDupuytren's contractureDupuytren's diseaseglaucomaeye pressure elevationintraocular pressure elevationprimary chronic glaucomamultiple sclerosisdisseminated demyleinating encephalomyelitisencephalomyelitis disseminataencephalitis disseminatacerebral polysclerosisamyotrophic lateral sclerosismyatrophic lateral sclerosismotoneuron diseaseLou Gehrig's syndromepostcovid syndromelongcovid syndrome; cellulose wool for medical use; reagents for analytical purposes for medical purposes; chemical reagents for medical use; enzyme preparations for veterinary purposes; reagent paper for medical or veterinary purposes; impregnated medicated wipes; medicinal preparations and substancesfor the treatment or prophylaxis of the nervous systemdrug for treatment orprophylaxis of the endocrine systemdrug for treatment or prophylaxis of cardiovascular systeminjectable pharmaceutical for treatment or prophylaxis of respiratory tractinjectable pharmaceutical for treatment or prophylaxis of gastro intestinal tractinjectable pharmaceutical for treatment or prophylaxis of kidney or urinary tractinjectable pharmaceutical for treatment or prophylaxis of skininjectable vitaminsinjectable antibioticsinjectable synthetic chemotherapeutic agentsinjectable antimyoticsinjectable pharmaceuticals for treatment or prophylaxis of mycobacteriainjectable pharmaceuticals for treatment or prophylaxis of parasitesinjectable pharmaceuticals for treatment or prophylaxis of virus infectionsinjectable cytokine agentsinjectable immune suppressive agentsinjectable distinfectant agentsinjectable pharmaceuticals for treatment of malignant tumorsinjectable pharmaceuticals for treatment or prophylaxis of extracellular matrixinjectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorderinjectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatoseheterozygous familial hypercholesterolemiadiabetic foot syndromearterial hypertension or cardiac insufficiencyinjectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan levelinjectable pharmaceutical for treatment or prophylaxis of Alzheimer's diseasevascular dementiaParkinson's diseasemultiple sclerosisamyotrophic lateral sclerosis ALScerbral insultbrain traumacerebral inflammationsautoimmune encephalitisinjectable pharmaceutical for treatment or prophylaxis of radiation diseaseinjectable pharmaceutical for treatment or prophylaxis of tendovaginitisenthesiopathyinsertion tendinosisinsertion tendinopathytendinitisperiarthritisperiathrosisarthosisosteoarthritisfibrosisrenal fibrosisliver fibrosiscardiac fibrosiscardiac valve fibrosispulmonary fibrosispulmonary cirrhosispulmonary sclerosiscerebral insultcerebral strokeapoplectic insultapoplexia cerebriictus apoplecticuscerebral infarctionbrain scarsgliosiscontracturefibrotendinous contracturefibrous contracturejoint contracturetendon contractureDupuytren's contractureDupuytren's diseaseglaucomaeye pressure elevationintraocular pressure elevationprimary chronic glaucomamultiple sclerosisdisseminated demyleinating encephalomyelitisencephalomyelitis disseminataencephalitis disseminatacerebral polysclerosisamyotrophic lateral sclerosismyatrophic lateral sclerosismotoneuron diseaseLou Gehrig's syndromepostcovid syndromelongcovid syndrome; reagents for microbiological analysis for veterinary purposes; impregnated medicated swabs; diagnostic reagents for medical use; enzymes for veterinary purposes; reagents for microbiological analysis for medical purposes; reagent paper for medical purposes; reagent paper for veterinary purposes; capillary stabilizing agents for medical purposes; diagnostic agents for medical use; wadding for medical purposes; dental preparations for disclosing plaque
Classe 10
Insulin syringes sold empty; genetic testing apparatus for medical purposes; diagnostic testing instruments for use in immunoassay procedure for medical use; testing apparatus for medical purposesgenetic testing apparatus for medical purposesDNA and RNA testing apparatus for medical purposesmedical diagnostic apparatus for testing for blood analysisplasma analysisserum analysisblood component analysisfeces analysisurine analysistissue analysistissue fliud analysisbody secretion analysis; membrane test plates for use in medical diagnostics; medical test kits for diabetes monitoring for home use; test probes for medical use; apparatus for carrying-out diagnostic tests for medical purposesultrasound diagnostic apparatusnuclear medical diagnostic imaging apparatusmedical apparatus for diagnostic radiopharmaceutical useorganoleptic diagnostic testing apparatus; diagnostic testing instruments for use in immunoassay procedure for medical purposes; testing apparatus for medical purposesfor immunochemical tesingdiagnostic apparatus for testing for viruses or bacteriagenetic testing apparatusapparatus for DAN and RNA testing for medical purposes; medical apparatus and instrumentsmedical radiation apparatusspirometerselectromagnetic medical diagnostic imaging apparatuselectromagnetic drug delivery apparatus for medical usemedical instruments for cutting tissuesmedical instruments for examing women's reproductive organsmedical instruments for use in general surgerymedical instruments for use in performing biopsies; medical apparatus for testing the level of glucose in the blood; chromatographic apparatus for medical purposes; medical diagnostic apparatus for medical purposesmedical ultrasound apparatusspirometerselectromagnetic medical diagnostic imaging apparatusmedical instruments for examining women's reproductive organsmedical instruments for use in performing biopsies; measuring devices for medical useblood pressureblood flowdevices for measuring woundsdevices for measuring body position and leg movements during sleepaudiometers for measuring hearing lossapparatus for measuring skin hydrationdevices measuring tumors; chromatographic devices for medical purposes; measuring instruments adapted for medical useblood pressureblood flowdevices for measuring woundsdevices for measuring body position and leg movements during sleepaudiometers for measuring hearing lossapparatus for measuring skin hydrationdevices measuring tumors; tongue depressors for medical purposes; apparatus for analysing substancesbody fluidsbloodbody tissuesbacterial culturesmucous for medical use; medical therapy instrumentsimplantable radiation therapy devices consisting of radioactive seedsmedical devices for moxibustion therapya device for improving cardiac performance through aortic flow therapy; blood collection tubes for medical use; chromatographic columns for medical use; medical diagnostic saliva vials; blood group analyzers for medical use; fibrescopes for medical use; chromatogram analyzers for medical use; medical analytical apparatus for medical purposesmedical ultrasound apparatusspirometerselectromagnetic medical diagnostic imaging apparatusmedical instruments for examining women's reproductive organsmedical instruments for use in performing biopsies; tools for medical diagnosticsmedical ultrasound apparatusspirometerselectromagnetic medical diagnostic imaging apparatusmedical instruments for examining women's reproductive organsmedical instruments for use in performing biopsies; automated analyzers for foreign matter contained in body fluids for medical use; chromatographic instruments for medical use; medical apparatus for diagnosing suspected heart attacks; diagnostic measuring apparatus for medical useblood pressureblood flowdevices for measuring woundsdevices for measuring body position and leg movements during sleepaudiometers for measuring hearing lossapparatus for measuring skin hydrationdevices meauring tumors; diagnostic apparatus for medical purposesmedical ultrasound apparatusspirometerselectromagnetic medical diagnostic imaging apparatusmedical instruments for examining women's reproductive organsmedical instruments for use in performing biopsies; apparatus for DNA and RNA testing for medical purposes; electronic apparatus for medical purposeselectronic medical appliances for wound healingelectronic temperature monitorselectronic muscle stimulatorsEKG machinesmedical apparatus for monitoring vital signsblood property and respiratory events; chromatography plates for medical use; chromatographic instruments for medical purposes; body composition analyzers for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/10/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
13/10/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/10/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/04/2022
PUBO
PUBLISHED FOR OPPOSITION
19/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/03/2022
ALIE
ASSIGNED TO LIE
14/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2022
RFNT
REFUSAL PROCESSED BY IB
01/08/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/07/2021
RFRR
REFUSAL PROCESSED BY MPU
14/07/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/07/2021
CNRT
NON-FINAL ACTION WRITTEN
12/07/2021
DOCK
ASSIGNED TO EXAMINER
07/07/2021
DOCK
ASSIGNED TO EXAMINER
28/06/2021
DOCK
ASSIGNED TO EXAMINER
18/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
18/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BELTEST-IT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.